• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖的医学和手术治疗。

Medical and Surgical Treatment of Obesity.

机构信息

Division of Endocrinology, Diabetes & Metabolism, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA; Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, 161 Fort Washington Avenue, Room 512, New York, NY 10032, USA.

Division of Endocrinology, Diabetes & Metabolism, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA; Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, 650 West 168th Street, Black Building, Room 20-08, New York, NY 10032, USA.

出版信息

Med Clin North Am. 2022 Sep;106(5):837-852. doi: 10.1016/j.mcna.2022.03.002. Epub 2022 Aug 26.

DOI:10.1016/j.mcna.2022.03.002
PMID:36154703
Abstract

During the past decade, several effective antiobesity medications and devices have been developed. In addition, new information regarding the mechanism of action, benefits, and long-term efficacy of bariatric surgery continues to emerge. More than 90% of patients who qualify for therapy for obesity remain untreated. This article aims to provide an overview of the indications and efficacy of currently available medical and surgical therapies for obesity, along with a look toward promising therapies on the horizon.

摘要

在过去的十年中,已经开发出了几种有效的减肥药和设备。此外,有关减肥手术作用机制、益处和长期疗效的新信息也不断涌现。超过 90%符合肥胖症治疗条件的患者未得到治疗。本文旨在概述目前可用的肥胖症药物和手术治疗的适应证和疗效,并展望未来有前途的治疗方法。

相似文献

1
Medical and Surgical Treatment of Obesity.肥胖的医学和手术治疗。
Med Clin North Am. 2022 Sep;106(5):837-852. doi: 10.1016/j.mcna.2022.03.002. Epub 2022 Aug 26.
2
Combination Therapies: Anti-Obesity Medications and Endoscopic Bariatric Procedures.联合治疗:抗肥胖症药物和内镜减重手术。
Gastrointest Endosc Clin N Am. 2024 Oct;34(4):743-756. doi: 10.1016/j.giec.2024.06.003. Epub 2024 Aug 16.
3
Treating the Chronic Disease of Obesity.治疗肥胖这一慢性疾病。
Med Clin North Am. 2021 Nov;105(6):983-1016. doi: 10.1016/j.mcna.2021.06.005.
4
Approaches to obesity management.肥胖管理方法。
Intern Med J. 2017 Jul;47(7):734-739. doi: 10.1111/imj.13474.
5
Best Practices in the Management of Overweight and Obesity.超重和肥胖管理的最佳实践。
Med Clin North Am. 2021 Jan;105(1):149-174. doi: 10.1016/j.mcna.2020.08.018. Epub 2020 Nov 7.
6
Review of Advances in Anti-obesity Pharmacotherapy: Implications for a Multimodal Treatment Approach with Metabolic Surgery.肥胖症药物治疗进展述评:代谢手术多模式治疗方法的启示。
Obes Surg. 2019 Dec;29(12):4095-4104. doi: 10.1007/s11695-019-04206-7.
7
Fundamentals of cardiometabolic risk factor reduction: achieving and maintaining weight loss with pharmacotherapy or bariatric surgery.降低心脏代谢危险因素的基础:通过药物治疗或减肥手术实现并维持体重减轻
Clin Cornerstone. 2008;9(1):41-8; discussion 49-51. doi: 10.1016/s1098-3597(08)60027-7.
8
Obesity: Lifestyle management, bariatric surgery, drugs, and the therapeutic exploitation of gut hormones.肥胖症:生活方式管理、减肥手术、药物以及肠道激素的治疗性应用。
Postgrad Med. 2015 Jun;127(5):494-502. doi: 10.1080/00325481.2015.1048181.
9
[Pharmacotherapy of obesity-Competition to bariatric surgery or a meaningful supplement?].[肥胖症的药物治疗——减肥手术的竞争还是有意义的补充?]
Chirurgie (Heidelb). 2023 Jun;94(6):497-505. doi: 10.1007/s00104-023-01830-z. Epub 2023 Mar 14.
10
Reviewing the impact of obesity on inflammatory bowel disease and considerations for optimizing management.肥胖对炎症性肠病的影响评估及优化管理的考虑因素。
Curr Opin Gastroenterol. 2024 Jul 1;40(4):268-275. doi: 10.1097/MOG.0000000000001025. Epub 2024 Apr 15.

引用本文的文献

1
WGCNA-Based Identification of Hub Genes and Key Pathways Involved in Obesity.基于加权基因共表达网络分析(WGCNA)鉴定肥胖相关的枢纽基因和关键通路
Mol Biotechnol. 2025 Sep 16. doi: 10.1007/s12033-025-01503-8.
2
Efficacy and safety of endoscopic gastroplasty for treatment of obesity: An overview of comparative meta-analyses.内镜胃成形术治疗肥胖症的疗效与安全性:比较性荟萃分析概述
World J Gastrointest Endosc. 2025 May 16;17(5):105158. doi: 10.4253/wjge.v17.i5.105158.
3
Association Between Visceral Adipose Tissue and Chronic Respiratory Diseases: A Two-Sample Multivariable Mendelian Randomization Study in European Population.
内脏脂肪组织与慢性呼吸道疾病之间的关联:欧洲人群中的双样本多变量孟德尔随机化研究
Int J Chron Obstruct Pulmon Dis. 2025 Apr 2;20:919-928. doi: 10.2147/COPD.S510828. eCollection 2025.
4
Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss.使用胰高血糖素样肽-1(GLP-1)激动剂减重及维持体重减轻的停药途径。
Biomolecules. 2025 Mar 13;15(3):408. doi: 10.3390/biom15030408.
5
RNA Modification in Metabolism.新陈代谢中的RNA修饰
MedComm (2020). 2025 Mar 10;6(3):e70135. doi: 10.1002/mco2.70135. eCollection 2025 Mar.
6
Lithium Intoxication After Sleeve Gastrectomy: A Case Report and Differential Diagnosis.袖状胃切除术后锂中毒:一例报告及鉴别诊断
Noro Psikiyatr Ars. 2024 Nov 30;61(4):374-376. doi: 10.29399/npa.28653. eCollection 2024.
7
Methylphenidate can help reduce weight, appetite, and food intake-a narrative review of adults' anthropometric changes and feeding behaviors.哌甲酯有助于减轻体重、降低食欲和减少食物摄入量——一项关于成年人人体测量学变化和进食行为的叙述性综述。
Front Nutr. 2024 Nov 29;11:1497772. doi: 10.3389/fnut.2024.1497772. eCollection 2024.
8
The anti-obesity effects of polyphenols: a comprehensive review of molecular mechanisms and signal pathways in regulating adipocytes.多酚的抗肥胖作用:调节脂肪细胞分子机制和信号通路的综合综述
Front Nutr. 2024 Oct 30;11:1393575. doi: 10.3389/fnut.2024.1393575. eCollection 2024.
9
Obesity and cardiovascular risk: a primer for the clinician.肥胖与心血管风险:临床医生入门指南
Arch Cardiol Mex. 2024 Oct 18;95(1):69-80. doi: 10.24875/ACM.24000123.
10
Complete genome sequence and anti-obesity potential of HOM2217 in 3T3-L1 cells and high-fat diet-fed rats.HOM2217在3T3-L1细胞和高脂饮食喂养大鼠中的全基因组序列及抗肥胖潜力
Front Microbiol. 2024 Sep 11;15:1436378. doi: 10.3389/fmicb.2024.1436378. eCollection 2024.